UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

21st century pharmacovigilance: efforts, roles, and responsibilities

The lancet oncology, 2016-11, Vol.17 (11), p.e486-e492

2016

Volltextzugriff (PDF)

Regulatory centaurs

Nature biotechnology, 2020-07, Vol.38 (7), p.788-789

Pitts, Peter J

2020

Volltextzugriff (PDF)

Female Problems: Women’s Health Mustn’t be Ghettoized in the Uterus

Pharmaceutical medicine, 2024-03, Vol.38 (2), p.75-77

Pitts, Peter J.

2024

Volltextzugriff (PDF)

The Pogo-ization of Post-Pandemic Vaccine Policy

The patient : patient-centered outcomes research, 2023-05, Vol.16 (3), p.179-181

Pitts, Peter J.

2023

Volltextzugriff (PDF)

Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic

Vaccine, 2024-05, Vol.42 (13), p.3145-3147

2024

Volltextzugriff (PDF)

Regulating Between the Notes: The US FDA and the Evolution of the Patient Voice Through Twenty-First Century Regulatory Science

The patient : patient-centered outcomes research, 2022-11, Vol.15 (6), p.611-613

Pitts, Peter J.

2022

Volltextzugriff (PDF)

Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates

Vaccine, 2023-08, Vol.41 (38), p.5483-5485

2023

Volltextzugriff (PDF)

Rejuvenating American Healthcare

Journal of commercial biotechnology, 2022-01, Vol.27 (1), p.39

Pitts, Peter J

2022

Volltextzugriff (PDF)

Health Literacy: The Common Denominator of Healthcare Progress

The patient : patient-centered outcomes research, 2021-09, Vol.14 (5), p.455-458

2021

Volltextzugriff (PDF)

Our Most Powerful Weapon to Fight COVID-19: Patient Involvement

The patient : patient-centered outcomes research, 2020-06, Vol.13 (3), p.255-255

Pitts, Peter J.

2020

Volltextzugriff (PDF)

Towards Meaningful Engagement for the Patient Voice

The patient : patient-centered outcomes research, 2019-08, Vol.12 (4), p.361-363

Pitts, Peter J.

2019

Volltextzugriff (PDF)

Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative

Saudi pharmaceutical journal, 2018-01, Vol.26 (1), p.71-74

2018

Volltextzugriff (PDF)

The Spreading Cancer of Counterfeit Drugs

Journal of commercial biotechnology, 2020-10, Vol.25 (3), p.20-33

Pitts, Peter

2020

Volltextzugriff (PDF)

Authors’ Reply to Ibrahim and Nair’s Comment on: “Health Literacy: The Common Denominator of Healthcare Progress”

The patient : patient-centered outcomes research, 2021-11, Vol.14 (6), p.871-871

2021

Volltextzugriff (PDF)

21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence

Journal of commercial biotechnology, 2017-01, Vol.23 (1), p.3

Pitts, Peter J

2017

Volltextzugriff (PDF)

Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated Action

Therapeutic innovation & regulatory science, 2023-01, Vol.57 (1), p.100-103

2023

Volltextzugriff (PDF)

Correction to: Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic

Therapeutic innovation & regulatory science, 2021-03, Vol.55 (2), p.462-462

2021

Volltextzugriff (PDF)

Can there be value-based medicine without … values?

Journal of commercial biotechnology, 2017-10, Vol.23 (4), p.6

Pitts, Peter J

2017

Volltextzugriff (PDF)

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Journal of commercial biotechnology, 2021-04, Vol.26 (2), p.20

2021

Volltextzugriff (PDF)

The Patient Voice: At the Intersection of a US Regulatory Revolution

The patient : patient-centered outcomes research, 2016-10, Vol.9 (5), p.373-377

Pitts, Peter J.

2016

Volltextzugriff (PDF)

Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic

Therapeutic innovation & regulatory science, 2021-01, Vol.55 (1), p.247-249

2021

Volltextzugriff (PDF)

Editorial Board Member’s Commentary: Commissioner Scott Gottlieb’s Predictable Imaginarium

Therapeutic innovation & regulatory science, 2017-11, Vol.51 (6), p.669-670

Pitts, Peter J.

2017

Volltextzugriff (PDF)

From the Valley of Death to the Crossroads of Opportunity: A Discussion of Evolving Benefit/Risk Evaluation Standards

Therapeutic innovation & regulatory science, 2018-09, Vol.52 (5), p.531-536

2018

Volltextzugriff (PDF)

Using Off-Label Communications to Responsibly Advance the Public Health

Therapeutic innovation & regulatory science, 2017-05, Vol.51 (3), p.322-326

Pitts, Peter J.

2017

Volltextzugriff (PDF)

Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment

Journal of commercial biotechnology, 2021-07, Vol.26 (3), p.3

2021

Volltextzugriff (PDF)

1 – 25 von 287

Menü

Weitere Dienste

Einstellungen

21st century pharmacovigilance: efforts, roles, and responsibilities

Regulatory centaurs

Female Problems: Women’s Health Mustn’t be Ghettoized in the Uterus

The Pogo-ization of Post-Pandemic Vaccine Policy

Addressing vaccine hesitancy: Learning from the successes and failures of the COVID-19 pandemic

Regulating Between the Notes: The US FDA and the Evolution of the Patient Voice Through Twenty-First Century Regulatory Science

Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates

Rejuvenating American Healthcare

Health Literacy: The Common Denominator of Healthcare Progress

Our Most Powerful Weapon to Fight COVID-19: Patient Involvement

Towards Meaningful Engagement for the Patient Voice

Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative

The Spreading Cancer of Counterfeit Drugs

Authors’ Reply to Ibrahim and Nair’s Comment on: “Health Literacy: The Common Denominator of Healthcare Progress”

21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence

Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated Action

Correction to: Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic

Can there be value-based medicine without … values?

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

The Patient Voice: At the Intersection of a US Regulatory Revolution

Patient Contribution to the Development and Safe Use of Medicines During the Covid-19 Pandemic

Editorial Board Member’s Commentary: Commissioner Scott Gottlieb’s Predictable Imaginarium

From the Valley of Death to the Crossroads of Opportunity: A Discussion of Evolving Benefit/Risk Evaluation Standards

Using Off-Label Communications to Responsibly Advance the Public Health

Vaccine Hesitancy: When Political Miscommunication Replaces Scientific Benefit/Risk Assessment

Suchergebnisse filtern